AGA: Consider Individualized Approach for Systemic Therapy in HCC

(MedPage Today) -- Systemic therapy for hepatocellular carcinoma (HCC) should generally be reserved for patients ineligible for curative surgery or locoregional therapy who have adequate liver function, the American Gastroenterological Association...